Dr Colin Howden on the Recent FDA Approval of Vonoprazan : v

Colin Howden, MD, discusses the mechanisms at work in vonoprazan as well as patient monitoring and potential future uses following a recent FDA approval for the treatment of erosive esophagitis.

Related Keywords

Colin Howden , University Of Tennessee Health Science Center , Tennessee Health Science Center , Vonoprazan , Erosive Esophagitis , Gerd , Potassium Competing Acid Blocker , Proton Pump Inhibitor , Pcab , Ppi ,